Possible short-term amelloration of basilar plaque by high-dose atorvastatin: Use of reductase inhibitors for intracranial plaque stabilization

被引：6

作者：

Callahan, AS

Berger, BL

Beuter, MJ

Devlin, TG

机构：

[1] Centennial Med Ctr, Stroke Serv, Nashville, TN 37203 USA

[2] Erlanger Med Ctr, Stroke Serv, Chattanooga, TN USA

来源：

JOURNAL OF NEUROIMAGING | 2001年 / 11卷 / 02期

关键词：

plaque regression; intracranial atherostenosis; atorvastatin; balloon angioplasty;

D O I：

10.1111/j.1552-6569.2001.tb00034.x

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Regression of symptomatic intracranial atherostenosis is not known to be a common occurrence. In this case, delay of basilar reconstruction by endovascular means permitted serial angiographic assessment of plaque change. The use of high-dose atorvastatin over a 2-week period was associated with marked angiographic improvement. Medical programs of plaque stabilization may provide adjunctive benefit in patients with symotomatic intracranial disease.

引用

收藏

页码：202 / 204

页数：3

相关论文

共 11 条

[1] Natural history of stenosis from intracranial atherosclerosis by serial angiography [J].

Akins, PT ;

Pilgram, TK ;

Cross, DT ;

Moran, CJ .

STROKE, 1998, 29 (02) :433-438

[2] Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis [J].

Barnett, HJM ;

Taylor, W ;

Eliasziw, M ;

Fox, AJ ;

Ferguson, GG ;

Haynes, RB ;

Rankin, RN ;

Clagett, GP ;

Hachinski, VC ;

Sackett, DL ;

Thorpe, KE ;

Meldrum, HE ;

Spence, JD .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (20) :1415-1425

[3]

BERGER BL, 1997, INTERVEN NEURORAD S1, V3, P47

[4] Balloon angioplasty of intracranial arteries for stroke prevention [J].

Callahan, AS ;

Berger, BL .

JOURNAL OF NEUROIMAGING, 1997, 7 (04) :232-235

[5] Basilar artery endoprosthesis placement: Rescue therapy for recurrent thrombosis [J].

Callahan, AS ;

Berger, BL .

JOURNAL OF NEUROIMAGING, 2000, 10 (01) :47-48

[6] PRAVASTATIN, LIPIDS, AND ATHEROSCLEROSIS IN THE CAROTID ARTERIES (PLAC-II) [J].

CROUSE, JR ;

BYINGTON, RP ;

BOND, MG ;

ESPELAND, MA ;

CRAVEN, TE ;

SPRINKLE, JW ;

MCGOVERN, ME ;

FURBERG, CD .

AMERICAN JOURNAL OF CARDIOLOGY, 1995, 75 (07) :455-459

[7] Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase [J].

Endres, M ;

Laufs, U ;

Huang, ZH ;

Nakamura, T ;

Huang, P ;

Moskowitz, MA ;

Liao, JK .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) :8880-8885

[8]

PEDERSEN TR, 1994, LANCET, V344, P1383

[9] Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease [J].

Pitt, B ;

Waters, D ;

Brown, WV ;

van Boven, AJ ;

Schwartz, L ;

Title, LM ;

Eisenberg, D ;

Shurzinske, L ;

McCormick, LS .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (02) :70-76

[10] The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels [J].

Sacks, FM ;

Pfeffer, MA ;

Moye, LA ;

Rouleau, JL ;

Rutherford, JD ;

Cole, TG ;

Brown, L ;

Warnica, JW ;

Arnold, JMO ;

Wun, CC ;

Davis, BR ;

Braunwald, E .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) :1001-1009